Related Experiment Video
Updated: Mar 30, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Recent Taxonomic Developments with Candida and Other Opportunistic Yeasts
Mary E Brandt1, Shawn R Lockhart1
1Mycotic Diseases Branch, Centers for Disease Control and Prevention, 1600 Clifton Road; Mailstop G-11, Atlanta, GA 30333, USA.
Abstract:
Increases in susceptible patient populations and advances in identification methods have resulted in the continued recognition of novel yeasts as agents of human infection. Most of these agents are members of the well-recognized genera Candida, Cryptococcus, Trichosporon, and Rhodotorula. Some of these agents are "cryptic species," members of species complexes, and may not be detectable using classical carbohydrate assimilation-based methods of yeast identification. Such species require DNA- or MALDI-based methods for correct identification, although sporadic isolates may not routinely require delineation to the individual species level. The coming end of the fungal taxonomy rules requiring separate names for sexual and asexual forms of the same fungus will hopefully allow greater clarity, as names for medically important yeast can now be based on the needs of the medical mycology community and the common goal of better communication between laboratory and clinician.
Insights
Novel yeasts are increasingly recognized as human pathogens, particularly cryptic species. Advanced DNA or MALDI methods are crucial for accurate identification, improving communication between labs and clinicians.
Area of Science:
- Medical Mycology
- Clinical Microbiology
- Fungal Taxonomy
Background:
- Increasing recognition of novel yeasts as human pathogens.
- Commonly implicated genera include Candida, Cryptococcus, Trichosporon, and Rhodotorula.
- Cryptic species, part of species complexes, pose identification challenges.
Purpose of the Study:
- To highlight the challenges in identifying novel yeast pathogens.
- To emphasize the need for advanced identification methods.
- To discuss the impact of evolving fungal taxonomy on medical mycology.
Main Methods:
- Review of current yeast identification techniques.
- Discussion of limitations of classical carbohydrate assimilation methods.
- Highlighting the utility of DNA-based and MALDI-TOF mass spectrometry.
Main Results:
- Cryptic yeast species often require molecular or mass spectrometry-based identification.
- Classical methods may fail to accurately identify certain medically important yeasts.
- Evolving fungal taxonomy rules aim to simplify nomenclature for medically relevant fungi.
Conclusions:
- Accurate identification of yeast pathogens is critical for patient care.
- Advanced identification methods are essential for detecting cryptic species.
- Standardized nomenclature will improve communication and clinical practice.
Related Concept Videos
Fungal Phylum Ascomycota
Fungal Group Zygomycota
Applications of Molecular Taxonomy
Overview of Fungi
Fungal Phylum Microsporidia
Antifungal Agents

